Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07310862) titled 'Virtual Reality - Gamma Sensory Stimulation for Improving Fatigue in People With Multiple Sclerosis' on Dec. 16, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Clarity Health Technologies, Inc

Condition: Multiple Sclerosis

Intervention: Device: Virtual Reality Gamma Sensory Stimulation

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: February 1, 2026

Target Sample Size: 30

Countries of Recru...